Can a Person Experience Recurrent Annual Shingles Outbreaks?
Yes, individuals can experience recurrent herpes zoster (shingles) episodes, though this occurs in a minority of patients—approximately 4-6% of immunocompetent individuals will have at least one recurrence, with higher rates (up to 18%) in immunocompromised populations. 1, 2
Recurrence Rates and Timing
In the general population, recurrent shingles occurs in approximately 1.2-9.6% of individuals who have had an initial episode, with an incidence rate of 1.7-16.6 cases per 1,000 person-years. 1
Immunocompromised individuals face substantially higher recurrence rates of 0-18.2%, with an incidence rate of 17.0-55 cases per 1,000 person-years—up to 3-5 times higher than immunocompetent populations. 1
The mean time between first and recurrent episodes is approximately 2 years for those aged 45-54 years and 3 years for those aged 55 years and older. 3
After the first 12 months following initial shingles, recurrence risk stabilizes at approximately 12 cases per 1,000 person-years and remains consistent for at least 8 years. 3
Multiple recurrences are possible but uncommon—in one large cohort, 49 patients experienced two recurrences and 3 patients had three recurrences. 2
Key Risk Factors for Recurrence
Female sex is a significant risk factor, with women experiencing recurrence rates of 7.63% compared to 4.73% in men. 2
Immunocompromised status (including HIV infection, organ transplant recipients, cancer patients, and those on immunosuppressive therapy) dramatically increases recurrence risk. 4, 1
Younger age at initial episode paradoxically increases recurrence risk compared to older individuals. 3
Family history of herpes zoster and comorbidities such as diabetes mellitus are associated with higher recurrence rates. 1
Long-lasting pain after the initial episode and the presence of herpes zoster ophthalmicus may predispose individuals to recurrence. 1
Clinical Patterns of Recurrence
Recurrence in the same dermatome occurs in approximately 16.3% of cases, and when same-dermatome recurrence happens, it more frequently affects the left side. 2
Having experienced one episode of shingles actually reduces the risk of subsequent episodes to 31.7% of the incidence seen in shingles-naive populations, suggesting some degree of immune boosting from the initial episode. 2
Prevention of Recurrence
The recombinant zoster vaccine (RZV/Shingrix) is recommended even for individuals who have already experienced shingles, as approximately 10% of patients experience recurrence within 10 years. 5
Vaccination should be delayed at least 2 months after an acute shingles episode before administering the vaccine. 5
RZV requires two doses given 2-6 months apart and is the preferred formulation over the older live-attenuated vaccine due to superior efficacy and safety in immunocompromised individuals. 5, 6
Important Clinical Caveats
Annual recurrences (every single year) would be exceptionally rare—the data suggest most recurrences happen years apart rather than annually, though immunocompromised patients may experience more frequent episodes. 1, 3
In approximately 6% of the general population, a second attack may occur, usually several decades after the first, emphasizing that while recurrence is possible, frequent annual episodes are not the typical pattern. 7
Patients experiencing unusually frequent recurrences should be evaluated for underlying immunosuppression or other predisposing conditions. 4, 1